-
SARS-CoV-2 N Protein Rewires GADD34 Antiviral Signaling
2026-09-17
Liu et al. identify a mechanism in which SARS-CoV-2 nucleocapsid protein redirects GADD34 mRNA into atypical N+/G3BP1+ foci, weakening IRF3-dependent interferon production. The study links stress-granule remodeling to viral immune evasion and provides a mechanistic framework for evaluating host–virus RNA stress responses.
-
Electroporation for CRISPR Editing in Mouse Zygotes
2026-09-16
Hashimoto and Takemoto established electroporation as a scalable alternative to microinjection for delivering CRISPR/Cas9 RNA into mouse zygotes with an intact zona pellucida. Their optimized workflow supported both targeted disruption and ssODN-mediated knock-in, providing a practical foundation for higher-throughput genome editing in mouse embryos.
-
Estradiol–Autophagy Axis in Perimenopausal Aging
2026-09-16
This study integrates NHANES associations, a perimenopausal mouse model, network pharmacology, and pharmacological validation to examine how declining estradiol may affect the heart, aorta, and kidneys. Its central contribution is evidence that receptor-dependent autophagy is a shared mechanism linking estrogen exposure with reduced multi-organ fibrosis, while the observational human data remain associative rather than causal.
-
Quercetin in LPS-Induced Depression: NLRP3 Insights
2026-09-15
A 2026 pre-proof study examines how quercetin affects depressive-like behavior and cognitive impairment in an LPS-induced mouse model, linking its activity to suppression of hippocampal and microglial NLRP3-associated inflammation. The findings position quercetin as an experimental anti-inflammatory agent for neurobehavioral research while highlighting the need for dose, pharmacokinetic, and human validation studies.
-
NF449 and Selective Platelet P2X1 Blockade
2026-09-15
The reference study established NF449 as a pharmacological tool for selectively probing platelet P2X1 signaling and showed that receptor blockade can reduce platelet activation and experimental thrombosis. Its combination of receptor-level assays, platelet function studies, and mouse thrombosis models provides a framework for separating P2X1-dependent effects from broader platelet and thrombin mechanisms.
-
5-EdU for S Phase DNA Synthesis Assays
2026-09-14
Use 5-EdU to measure active DNA synthesis with a rapid click-chemistry workflow that preserves morphology and antigen accessibility. The approach is especially useful for stem-cell studies, tissue regeneration studies, tumor growth research, and scalable cell proliferation assays.
-
Oleanolic Acid: From Mechanism to Measurement
2026-09-14
Oleanolic acid links inducible nitric oxide synthase induction with demanding liposome analytics. This article presents a measurement-first framework for separating formulation performance from immune and antiviral biology.
-
Protease and Phosphatase Inhibitor Cocktail
2026-09-13
The Protease and Phosphatase Inhibitor Cocktail K4006 is an EDTA-free, 100X reagent for protecting proteins and phosphorylation states during biological sample lysis. Its broad inhibitor coverage supports protein extraction, proteomics, and cell-signaling workflows, while the cited HMGB1 study provides biological context rather than direct validation of this product.
-
H5N1 mRNA Vaccine Protects Lactating Dairy Cows
2026-09-12
A hemagglutinin-encoding mRNA–lipid nanoparticle vaccine protected lactating dairy cows from high-dose H5N1 challenge and did not measurably disrupt health or milk production. The study is notable because protection persisted in most animals at a late time point despite very low serum antibody levels, supporting further investigation of mRNA vaccination in production-relevant hosts.
-
2'-O-Methyladenosine Workflow Guide
2026-09-11
Build better RNA modification nucleoside experiments with 2'-O-Methyladenosine as an authentic analytical standard, defined cell-treatment input, and transport-assay probe. This guide connects matrix-aware UHPLC–MS/MS, cell extraction, and troubleshooting so free-nucleoside measurements are not confused with transcript-level RNA mapping.
-
Indomethacin Workflows for Inflammation and Lipid Biology
2026-09-11
Indomethacin supports more than routine cyclooxygenase inhibition: it can help separate COX-dependent inflammation from PPAR-linked adipocyte biology and membrane organization. This practical guide pairs dose-controlled workflows with the SEMA3E beige-adipocyte study to improve assay design, interpretation, and troubleshooting.
-
MK-4827 Workflows for PARP Inhibition Research
2026-09-10
MK-4827 (Niraparib) enables controlled PARP-1/-2 inhibition for BRCA-mutant models, DNA damage response assays, and radiosensitization studies. This workflow connects concentration planning, spliceosome-informed HCC experiments, combination testing, and troubleshooting in one practical research framework.
-
Tubastatin A: From HDAC6 Target to Cell Fate
2026-09-10
Tubastatin A is a selective HDAC6 inhibitor whose value extends beyond α-tubulin acetylation. This article shows how to interpret target engagement, regulated cell-death readouts, and translational evidence from a porcine cardiac-arrest model without overstating causality.
-
BMX-IN-1: From Kinase Mechanism to Translation
2026-09-09
BMX-IN-1 provides a selective, irreversible way to interrogate BMX kinase across cancer biology and host–pathogen research. New evidence linking BMX-dependent ATP6V1E1 phosphorylation to lysosomal acidification in Mycobacterium tuberculosis creates a practical framework for connecting target engagement with cell-cycle, apoptosis, and intracellular survival phenotypes.
-
Gemcitabine as a GPX3–JNK Assay Probe
2026-09-09
Gemcitabine is more than a DNA synthesis inhibitor: it can expose how GPX3–JNK/c-Jun signaling shapes pancreatic cancer drug sensitivity. This article translates the reference study into a practical assay strategy for apoptosis, DNA damage response, and chemoresistance research.